Novation, a healthcare industry supply contracting company, announces that NOVAPLUS® and Kimberly-Clark Health Care are hosting a sourcing event for products providers need in the event of a pandemic. The members of VHA, University HealthSystem Consortium (UHC) and Provista gain exclusive market value for pre-commitment of N95 respirators, standard masks and select gowns.
"With the flu season right around the corner, healthcare providers need to know that they have the products they need to effectively execute their pandemic preparedness plan," said Cathy Denning, Novation vice president. "This sourcing event with Kimberly-Clark will give the members we serve the confidence to know they have what they need when managing patients during this time."
The sourcing event is effective through Oct. 1 and all deliveries must take place by December 31, 2010. Participating members will receive a rebate equal to 3 percent of the total amount purchased through this sourcing event.
NOVAPLUS, Novations private label brand of pharmacy and medical-surgical products, delivers the best financial value for VHA, UHC and Provista members on the most frequently purchased commodity products. Originally founded in 1985 as VHAPLUS, the private label currently includes more than 1,100 products with annual purchases of $1.4 billion.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
Breaking the Cycle: Long COVID's Impact and the Urgent Need for Preventative Measures
November 15th 2024Masking, clean air, and vaccinations are essential in combating COVID-19 and preventing long-term impacts, as evidence mounts of long COVID's significant economic, cognitive, and behavioral effects.
The Critical Role of Rapid Diagnostics in Antibiotic Stewardship
November 6th 2024Rapid diagnostics enhance patient outcomes by enabling prompt, targeted treatments, reducing inappropriate antibiotic use, and combating antimicrobial resistance through informed clinical decisions and stewardship programs.